Prevalence, severity, and risk factors of liver disease in blood donors positive in a second-generation anti?hepatitis c virus screening test*1, *2

Hepatology ◽  
1995 ◽  
Vol 21 (3) ◽  
pp. 725-729 ◽  
Author(s):  
L SERFATY
Hepatology ◽  
1995 ◽  
Vol 21 (3) ◽  
pp. 725-729 ◽  
Author(s):  
Lawrence Serfaty ◽  
Jean Baptiste Nousbaum ◽  
Marie Helene Elghouzzi ◽  
Phillipe Giral ◽  
Claire Legendre ◽  
...  

2021 ◽  
pp. 003335492110472
Author(s):  
Hope King ◽  
J. E. Soh ◽  
William W. Thompson ◽  
Jessica Rogers Brown ◽  
Karina Rapposelli ◽  
...  

Objective Approximately 2.4 million people in the United States are living with hepatitis C virus (HCV) infection. The objective of our study was to describe demographic and socioeconomic characteristics, liver disease–related risk factors, and modifiable health behaviors associated with self-reported testing for HCV infection among adults. Methods Using data on adult respondents aged ≥18 from the 2013-2017 National Health Interview Survey, we summarized descriptive data on sociodemographic characteristics and liver disease–related risk factors and stratified data by educational attainment. We used weighted logistic regression to examine predictors of HCV testing. Results During the study period, 11.7% (95% CI, 11.5%-12.0%) of adults reported ever being tested for HCV infection. Testing was higher in 2017 than in 2013 (adjusted odds ratio [aOR] = 1.27; 95% CI, 1.18-1.36). Adults with ≥some college were significantly more likely to report being tested (aOR = 1.60; 95% CI, 1.52-1.69) than adults with ≤high school education. Among adults with ≤high school education (but not adults with ≥some college), those who did not have health insurance were less likely than those with private health insurance (aOR = 0.78; 95% CI, 0.68-0.89) to get tested, and non–US-born adults were less likely than US-born adults to get tested (aOR = 0.77; 95% CI, 0.68-0.87). Conclusions Rates of self-reported HCV testing increased from 2013 to 2017, but testing rates remained low. Demographic characteristics, health behaviors, and liver disease–related risk factors may affect HCV testing rates among adults. HCV testing must increase to achieve hepatitis C elimination targets.


Transfusion ◽  
2004 ◽  
Vol 44 (10) ◽  
pp. 1433-1440 ◽  
Author(s):  
Lakkana Thaikruea ◽  
Satawat Thongsawat ◽  
Niwat Maneekarn ◽  
Dale Netski ◽  
David L. Thomas ◽  
...  

Pharmacophore ◽  
2021 ◽  
Vol 12 (5) ◽  
pp. 32-37
Author(s):  
Abdoalrhman Abdaltif ◽  
Mohammed Degail Abdallah ◽  
Marwa Yousif Yagowb ◽  
Mustafa Gamal Mustafa ◽  
Taha Algilani Alameen ◽  
...  

1994 ◽  
Vol 112 (3) ◽  
pp. 595-601 ◽  
Author(s):  
K. R. Neal ◽  
D. A. Jones ◽  
D. Killey ◽  
V. James

SUMMARYThe introduction of screening for hepatitis C virus (HCV) by the National Blood Transfusion Service identified donors who had acquired HCV infection. We undertook a case-control study amongst blood donors in the Trent Region to determine risks for HCV infection. A total of 74 blood donors confirmed positive for hepatitis C infection and 150 age, sex and donor venue matched controls were included in the study. Fifty-three percent of hepatitis C infected blood donors reported previous use of injected drugs compared to no controls; relative risk (RR) not estimatable (lower limit 95% CI = 20). Other risk factors were a history of: receipt of a blood transfusion or blood products RR = 3·6 (95% CI 1·5–8·3), having been a ‘health care worker’ RR = 2·8 (95% CI 1·1–7·6), tattooing RR = 3·3 (95% CI 1·2–8·7), and an association with having been born abroad RR = 3·2 (95% CI 1·1–9·5). No risk was shown for a history of multiple sexual partners, ear piercing or acupuncture. Injecting drug use explains more than 50% of hepatitis C infections in blood donors, a group who are less likely to have injected drugs than the general population.


Sign in / Sign up

Export Citation Format

Share Document